Kura Oncology, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
KURA Nasdaq 2836 kuraoncology.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Kura Oncology, Inc.

Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML - Jun 11th, 2026 6:02 am
How The Kura Oncology (KURA) Investment Narrative Is Evolving Without New Analyst Revisions - Jun 6th, 2026 2:07 am
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 5th, 2026 5:30 am
Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy - Jun 3rd, 2026 4:53 am
Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML - Jun 2nd, 2026 6:32 am
Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors - May 26th, 2026 4:02 am
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit - May 19th, 2026 2:02 pm
Some Analysts Just Cut Their Kura Oncology, Inc. (NASDAQ:KURA) Estimates - May 17th, 2026 7:22 am
Earnings Update: Kura Oncology, Inc. (NASDAQ:KURA) Just Reported And Analysts Are Trimming Their Forecasts - May 15th, 2026 7:10 am
Kura Oncology, Inc. Q1 2026 Earnings Call Summary - May 13th, 2026 6:30 am
Kura Oncology Inc (KURA) Q1 2026 Earnings Call Highlights: Strong KOMZIFTI Launch Amid Rising ... - May 12th, 2026 11:02 pm
Kura Oncology Q1 Earnings Call Highlights - May 12th, 2026 7:09 pm
Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates - May 12th, 2026 3:15 pm
Kura Oncology Reports First Quarter 2026 Financial Results - May 12th, 2026 2:02 pm
Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress - May 12th, 2026 7:40 am
Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 3:55 pm
Kura Oncology to Participate in Bank of America Securities Healthcare Conference - May 6th, 2026 5:30 am
Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know - May 5th, 2026 8:00 am
Kura Oncology to Report First Quarter 2026 Financial Results - May 5th, 2026 5:30 am
How The Kura Oncology (KURA) Story Is Evolving After Komzifti Launch And Q4 Reassessment - May 4th, 2026 5:14 pm